Stock listing

MYX Stock Price, News, Filings & Events — Mayne Pharma Group Ltd.

Selected listing: MYX · ASX · AUD · AU

This page tracks Mayne Pharma Group Ltd.'s MYX:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MYX:ASX. MYX:ASX is the stock-level entry point for investors researching Mayne Pharma Group Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mayne Pharma Group Ltd. (Ticker: MYX) is a public company based in Australia, with a market capitalization of approximately AUD 156.29 million. The company specializes in the development and commercialization of pharmaceutical products. Mayne Pharma is focused on providing high-quality medicines to improve patient outcomes.